Day: March 10, 2026

Rituximab Infusion Protocol: A Comprehensive Overview Rituximab, a chimeric monoclonal antibody, targets CD20+ B cells, offering therapeutic benefits across various conditions. This protocol details its administration, monitoring, and management of potential adverse events, referencing NCCN guidelines and recent research from Kuchinskaya, Molochkov, Abdurashidova, and Polushin. Rituximab therapy...